Table 2: Incident rate of CV events in 86 patients treated with anti-TNF alfa (TNF+) and 258 patients treated with DMARDs (TNF-).
Exposure | n. patients | Patient-years (×100) | CV events/100 patients/year |
TNF+ | 86 | 855.87 | 2.4 |
TNF- | 258 | 3452.62 | 1.27 |